
	Concert Pharmaceuticals has announced the appointment of Ryan Daws as Chief Financial Officer on January 23, 2014. Mr. Daws brings to Concert more than 15 years of capital markets and financial advisory experience in the biotechnology and healthcare industry. Mr. Daws joins Concert with significant strategic and transactional experience within the healthcare industry. He has been involved in numerous equity and merger and acquisition transactions. Prior to joining Concert he was a Director in the Healthcare Investment Banking Group from 2010 to 2013 at Stifel, Nicolaus &amp; Company, Inc., a financial services company. From 1999 to 2010, he served in positions of increasing responsibility within the Healthcare Investment Banking Group of Cowen and Company, LLC, a financial services firm. Mr. Daws holds a B.S. in Finance and Organizational Management from the University of South Carolina and an International M.B.A. from the University of South Carolina&rsquo;s Moore School of Business.
